The BRaf gain-of-function Val to Glu mutation is required for cell viability, anchorage-independent growth, and proliferation of BRafV600E-positive melanoma cell lines in both cell-based studies and in vivo mouse models [9–11]. This evidence concerns the gene BRAF and melanoma.